Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Jiangsu Alphamab Biopharmaceuticals Co., Ltd"
Count: 27
Selected: 0
NCT04601610KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma
NCT06226766JSKN033 in Patients With Advanced or Metastatic Solid Malignant Tumors
NCT05149326KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma.
NCT04469725KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma
NCT03925974KN026 in Patients With HER2 Expressing Gastric/Gastroesophageal Junction Cancer
NCT03619681Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer
NCT06079983JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
NCT05309512Clinical Study of KN052 in Chinese Subjects With Advanced Solid Tumors
NCT04521179Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors
NCT04165993Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer
NCT05744427To Evaluate the Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors
NCT04778982Study of KN026 in Combination With Palbociclib and Fulvestrant in Patients With Advanced Breast Cancer
NCT03733951KN046 in Subjects With Advanced Solid Tumors and Lymphoma
NCT03872791A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast Cancer
NCT05001724KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent
NCT03838848KN046 in Patients With Advanced Non-small Cell Lung Cancer
NCT04038970Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
NCT05420220Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer
NCT03925870KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma
NCT04881929Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
NCT04474119KN046 in Subjects With Advanced Squamous Non-small Cell Lung Cancer
NCT03847168KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer
NCT04054531Study of KN046 With Chemotherapy in First Line Advanced NSCLC
NCT04612712A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors
NCT04925947A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors
NCT04040699KN026 Combined With KN046 in Subjects With HER2 Positive Solid Tumor
NCT04984668A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors